ATLANTA, GA – – (Globe Newswire – August 22, 2024) – – A shareholder class action lawsuit has been filed against DexCom, Inc. (“DexCom” or “the Company”) (NASDAQ: DXCM). The lawsuit alleges that Defendants created the false impression that they possessed reliable information pertaining to the Company’s projected revenue outlook and anticipated growth while also minimizing risk from seasonality and macroeconomic fluctuations. Such statements are alleged to have caused Plaintiff and other shareholders to purchase DexCom’s securities at artificially inflated prices.

If you bought shares of DexCom between January 8, 2024 and July 25, 2024, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/dexcom/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is October 21, 2024.